VICTORY CAPITAL MANAGEMENT INC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1040188
San Antonio, TX
Position in CLDX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,072,913
+$203,088 QoQ
Shares Held
28,834
+5.1% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#122
of 252 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. CLDX ranks #73 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in CLDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,072,913 | 28,834 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $869,825 | 27,422 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $744,971 | 27,429 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $708,579 | 27,390 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $562,677 | 27,650 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $202,235 | 8,003 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $277,018 | 8,150 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $307,997 | 8,322 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $345,622 | 8,235 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $287,614 | 7,252 | Shares | Sole | 2024-02-05 | |
| 2022-12-31 | $227,128 | 5,096 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $330,826 | 11,769 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $503,801 | 18,687 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $593,461 | 17,424 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $598,494 | 15,489 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,062,361 | 19,677 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $773,567 | 23,133 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $551,359 | 26,765 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $293,512 | 16,753 | Shares | Sole | 2021-02-01 | |
| 2020-03-31 | $3,652 | 2,200 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||